These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 9353014

  • 21. Immunization with the MAEBL M2 Domain Protects against Lethal Plasmodium yoelii Infection.
    Leite JA, Bargieri DY, Carvalho BO, Albrecht L, Lopes SC, Kayano AC, Farias AS, Chia WN, Claser C, Malleret B, Russell B, Castiñeiras C, Santos LM, Brocchi M, Wunderlich G, Soares IS, Rodrigues MM, Rénia L, Costa FT.
    Infect Immun; 2015 Oct; 83(10):3781-92. PubMed ID: 26169268
    [Abstract] [Full Text] [Related]

  • 22. Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection.
    Marussig M, Rénia L, Motard A, Miltgen F, Pétour P, Chauhan V, Corradin G, Mazier D.
    Int Immunol; 1997 Dec; 9(12):1817-24. PubMed ID: 9466309
    [Abstract] [Full Text] [Related]

  • 23. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
    Wang R, Charoenvit Y, Corradin G, De La Vega P, Franke ED, Hoffman SL.
    J Immunol; 1996 Nov 01; 157(9):4061-7. PubMed ID: 8892640
    [Abstract] [Full Text] [Related]

  • 24. Protective immune responses elicited by immunization with a chimeric blood-stage malaria vaccine persist but are not boosted by Plasmodium yoelii challenge infection.
    Alaro JR, Lynch MM, Burns JM.
    Vaccine; 2010 Oct 04; 28(42):6876-84. PubMed ID: 20709001
    [Abstract] [Full Text] [Related]

  • 25. Antigenic and sequence diversity at the C-terminus of the merozoite surface protein-1 from rodent malaria isolates, and the binding of protective monoclonal antibodies.
    Benjamin PA, Ling IT, Clottey G, Valero LM, Ogun SA, Fleck SL, Walliker D, Morgan WD, Birdsall B, Feeney J, Holder AA.
    Mol Biochem Parasitol; 1999 Nov 30; 104(2):147-56. PubMed ID: 10593171
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A new malaria antigen produces partial protection against Plasmodium yoelii challenge.
    Zhang Y, Qi Y, Li J, Liu S, Hong L, Lin T, Long C, Su XZ.
    Parasitol Res; 2012 Apr 30; 110(4):1337-45. PubMed ID: 21915626
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Oral immunization with a combination of Plasmodium yoelii merozoite surface proteins 1 and 4/5 enhances protection against lethal malaria challenge.
    Wang L, Goschnick MW, Coppel RL.
    Infect Immun; 2004 Oct 30; 72(10):6172-5. PubMed ID: 15385527
    [Abstract] [Full Text] [Related]

  • 32. Immunization against malaria with a recombinant protein.
    Ling IT, Ogun SA, Holder AA.
    Parasite Immunol; 1994 Feb 30; 16(2):63-7. PubMed ID: 8015856
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Definition of T cell epitopes within the 19 kDa carboxylterminal fragment of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) and their role in immunity to malaria.
    Tian JH, Good MF, Hirunpetcharat C, Kumar S, Ling IT, Jackson D, Cooper J, Lukszo J, Coligan J, Ahlers J, Saul A, Berzofsky JA, Holder AA, Miller LH, Kaslow DC.
    Parasite Immunol; 1998 Jun 30; 20(6):263-78. PubMed ID: 9651928
    [Abstract] [Full Text] [Related]

  • 35. Alteration in host cell tropism limits the efficacy of immunization with a surface protein of malaria merozoites.
    Shi Q, Cernetich A, Daly TM, Galvan G, Vaidya AB, Bergman LW, Burns JM.
    Infect Immun; 2005 Oct 30; 73(10):6363-71. PubMed ID: 16177307
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Defining rules of CD8(+) T cell expansion against pre-erythrocytic Plasmodium antigens in sporozoite-immunized mice.
    Billman ZP, Kas A, Stone BC, Murphy SC.
    Malar J; 2016 Apr 26; 15():238. PubMed ID: 27113469
    [Abstract] [Full Text] [Related]

  • 38. Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populations.
    Sedegah M, Brice GT, Rogers WO, Doolan DL, Charoenvit Y, Jones TR, Majam VF, Belmonte A, Lu M, Belmonte M, Carucci DJ, Hoffman SL.
    Infect Immun; 2002 Jul 26; 70(7):3493-9. PubMed ID: 12065488
    [Abstract] [Full Text] [Related]

  • 39. A hybrid multistage protein vaccine induces protective immunity against murine malaria.
    Singh B, Cabrera-Mora M, Jiang J, Moreno A.
    Infect Immun; 2012 Apr 26; 80(4):1491-501. PubMed ID: 22252877
    [Abstract] [Full Text] [Related]

  • 40. Cytokines and antibody subclass associated with protective immunity against blood-stage malaria in mice vaccinated with the C terminus of merozoite surface protein 1 plus a novel adjuvant.
    De Souza JB, Ling IT, Ogun SA, Holder AA, Playfair JH.
    Infect Immun; 1996 Sep 26; 64(9):3532-6. PubMed ID: 8751895
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.